BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38475928)

  • 1. An increase in SNHG5 expression is associated with poor cancer prognosis, according to a meta-analysis.
    Huang Q; Xia YG; Huang YJ; Qin HF; Zhang QX; Wei CF; Tang WR; Liao Y
    Eur J Med Res; 2024 Mar; 29(1):160. PubMed ID: 38475928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Value and Clinical Significance of lncRNA SNHG5 Expression in Patients with Multiple Malignancies: A Bioinformatic and Meta-Analysis.
    Pashirzad M; Sahebkar A
    Curr Cancer Drug Targets; 2024 Feb; ():. PubMed ID: 38409690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis.
    Shen GY; Huang RZ; Yang SB; Shen RQ; Gao JL; Zhang Y
    BMC Cancer; 2023 Dec; 23(1):1243. PubMed ID: 38104110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia.
    Li J; Sun CK
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3342-3347. PubMed ID: 29917184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
    Han H; Huang H; Chen AP; Tang Y; Huang X; Chen C
    PLoS One; 2024; 19(4):e0292726. PubMed ID: 38573879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Long Non-Coding RNA SNHG7 in Human Cancer: A Meta-Analysis.
    Yu K; Yuan W; Huang C; Xiao L; Xiao R; Zeng P; Chen L; Chen Z
    Curr Pharm Biotechnol; 2022; 23(7):946-958. PubMed ID: 34375186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
    Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
    Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
    Zhang C; Ren X; Liu Z; Tu C
    BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PANDAR as a prognostic marker in Chinese cancer.
    Ma PJ; Guan QK; Xu DW; Zhao J; Qin N; Jin BZ
    Clin Chim Acta; 2017 Dec; 475():172-177. PubMed ID: 29066211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
    Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
    BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
    Wang J; Zhong P; Hua H
    Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of long noncoding RNA CRNDE in cancer patients: a systematic review and meta-analysis.
    Wang W; Yuan F; Xu J
    Neoplasma; 2019 Jan; 66(1):73-82. PubMed ID: 30509091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG5: A new budding star in human cancers.
    Li YH; Hu YQ; Wang SC; Li Y; Chen DM
    Gene; 2020 Jul; 749():144724. PubMed ID: 32360843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEMIP as a prognostic biomarker for cancers: a meta- and bioinformatic analysis.
    Chen H; Wang Q; Liu J; Chen Y; Zhang Q; Chai L; Wang Y; Li D; Qiu Y; Li M
    Expert Rev Mol Diagn; 2022 Dec; 22(12):1107-1115. PubMed ID: 36631437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis.
    Shi D; Wu F; Gao F; Qing X; Shao Z
    PLoS One; 2017; 12(6):e0179346. PubMed ID: 28594897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.